0001181431-11-059307.txt : 20111207 0001181431-11-059307.hdr.sgml : 20111207 20111207164851 ACCESSION NUMBER: 0001181431-11-059307 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111012 FILED AS OF DATE: 20111207 DATE AS OF CHANGE: 20111207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CORR PETER B CENTRAL INDEX KEY: 0001176312 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-34641 FILM NUMBER: 111249002 MAIL ADDRESS: STREET 1: PFZER INC STREET 2: 235 EAST 42ND STREET CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Furiex Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001484478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271197863 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3900 PARAMOUNT PARKWAY STREET 2: SUITE 150 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-456-7800 MAIL ADDRESS: STREET 1: 3900 PARAMOUNT PARKWAY STREET 2: SUITE 150 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: PPD Therapeutics, Inc. DATE OF NAME CHANGE: 20100218 4/A 1 rrd327523.xml FORM 4/A X0304 4/A 2011-10-12 2011-10-14 0 0001484478 Furiex Pharmaceuticals, Inc. FURX 0001176312 CORR PETER B C/O FURIEX PHARMACEUTICALS, INC. 3900 PARAMOUNT PARKWAY, SUITE 150 MORRISVILLE NC 27560 1 0 0 0 Stock Options (to buy) 13.45 2011-10-12 4 A 0 8825 0.0 A 2021-10-12 Common Stock 8825 8825 D This amended Form 4 is being filed to correct the footnote description. The original Form 4 filed on October 14, 2011 incorrectly stated the options would vest in full on the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors. The corrected footnote appears in footnote #2. The options were awarded on October 12, 2011 and vest and become exercisable in full on the earlier of May 19, 2012 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors. /s/ Peter B. Corr 2011-12-07